The economic burden of advanced liver disease among patients with Hepatitis C Virus: a large state Medicaid perspective

The economic burden of advanced liver disease among patients with Hepatitis C Virus: a large state Medicaid perspective

<p>Abstract</p> <p>Background</p> <p>Chronic hepatitis C virus (HCV) may progress to advanced liver disease (ALD), including decompensated cirrhosis and/or hepatocellular carcinoma (HCC). ALD can lead to significant clinical and economic consequences, including liver tr...

Full description

Bibliographic Details
Main Authors:	Menzin Joseph, White Leigh Ann, Nichols Christine, Deniz Baris
Format:	Article
Language:	English
Published:	BMC 2012-12-01
Series:	BMC Health Services Research
Subjects:	Hepatocellular carcinoma Decompensated cirrhosis Cost Administrative claims databases Payers HCV Hepatitis C
Online Access:	http://www.biomedcentral.com/1472-6963/12/459

Similar Items

Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study
by: Shunichiro Fujiyama, et al.
Published: (2021-04-01)

Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy
by: Chih-Lin Lin, et al.
Published: (2020-10-01)

Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance
by: Maria Stella Franzè, et al.
Published: (2022-10-01)

Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis
by: Steven Flamm, et al.
Published: (2023-09-01)

An overview of Triple infection with Hepatitis B, C and D viruses
by: Kanwal Hifza, et al.
Published: (2011-07-01)

Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients
by: Kei Moriya, et al.
Published: (2019-12-01)

Disease progression and health care resource consumption in patients affected by hepatitis C virus in real practice setting
by: Perrone V, et al.
Published: (2016-10-01)

A validated risk model for prediction of early readmission in patients with hepatic encephalopathy
by: Andrew J. Kruger, et al.
Published: (2019-03-01)

Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?
by: Lucy Meunier, et al.
Published: (2022-12-01)

Predictors of residual hepatic reserve and hepatic decompensation in cirrhotic patients after ablated hepatocellular carcinoma treated by DDAs or systemic therapy
by: Amr Shaaban Hanafy, et al.
Published: (2021-10-01)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
by: Qingling Chen, et al.
Published: (2023-09-01)

Risk Factors for Liver Decompensation and HCC in HCV-Cirrhotic Patients after DAAs: A Multicenter Prospective Study
by: Filomena Morisco, et al.
Published: (2021-07-01)

Liver-related long-term outcomes of alpha-glucosidase inhibitors in patients with diabetes and liver cirrhosis
by: Fu-Shun Yen, et al.
Published: (2022-12-01)

Combined effects of hyponatremia and hepatic encephalopathy on inpatient mortality
by: Mahak Chauhan, et al.
Published: (2023-05-01)

Hepatitis B Co-Infection Has Limited Impact on Liver Stiffness Regression in Chronic Hepatitis C Patients Treated with Direct-Acting Antivirals
by: Cheng-Er Hsu, et al.
Published: (2022-04-01)

Comparison of clinical outcomes and impact of SVR in American and Chinese patients with chronic hepatitis C
by: Huiying Rao, et al.
Published: (2020-08-01)

The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain
by: M. Chris Runken, et al.
Published: (2019-07-01)

Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?
by: Francesco Paolo Russo, et al.
Published: (2022-01-01)

Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
by: Fu-Shun Yen, et al.
Published: (2021-06-01)

Combination with portosystemic shunt occlusion and antiviral therapy improves prognosis of decompensated cirrhosis
by: Hideyuki Tamai, et al.
Published: (2020-08-01)

Risk factors of unfavorable prognosis of chronic hepatitis C
by: S E Shchanitcyna, et al.
Published: (2019-02-01)

The Age, Gamma-Glutamyl Transpeptidase and Platelet Index: A Novel Noninvasive Model for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Related Liver Cirrhosis
by: Liu K, et al.
Published: (2022-10-01)

A new model predicts hepatocellular carcinoma in patients with HBV-related decompensated liver cirrhosis and long-term antiviral therapy: a prospective study
by: Hao-dan Mao, et al.
Published: (2023-03-01)

The impact of price transparency and competition on hospital costs: a research on all-payer claims databases
by: Ahreum Han, et al.
Published: (2022-11-01)

Platelets, mean platelet volume, lymphocytes, leukocytes, and ratios of them altered in patients with hepatitis B virus‐related decompensated cirrhosis
by: Changzhi Xu, et al.
Published: (2022-06-01)

Characteristics and health care utilization of otherwise healthy commercially and Medicaid-insured preterm and full-term infants in the US
by: McLaurin KK, et al.
Published: (2019-04-01)

Multi-morbidities are Not a Driving Factor for an Increase of COPD-Related 30-Day Readmission Risk
by: Lin S, et al.
Published: (2020-01-01)

Hepatic Hydrothorax—An Independent Decompensating Event Associated with Long-Term Mortality in Patients with Cirrhosis
by: Daniela Matei, et al.
Published: (2021-08-01)

Continued alcohol consumption and hepatic encephalopathy determine quality of life and psychosocial burden of caregivers in patients with liver cirrhosis
by: Michael Nagel, et al.
Published: (2022-02-01)

Neutrophil-to-lymphocyte ratio predicts 30-, 90-, and 180-day readmissions of patients with hepatic encephalopathy
by: Lin Zhang, et al.
Published: (2023-06-01)

Evaluation of five lymphocyte-based scores for prediction of mortality in hepatitis B virus-associated decompensated cirrhosis
by: Ting Mao, et al.
Published: (2023-08-01)

The impact and role of hepatic hydrothorax in the prognosis of patients with decompensated cirrhosis: A retrospective propensity score-matched study
by: Bo Ma, et al.
Published: (2022-09-01)

The distribution of hepatitis C virus genotypes in patients with hepatocellular carcinoma
by: Ayfer Bakır, et al.
Published: (2019-10-01)

The Natural History of Hepatitis C Virus (HCV) Infection
Published: (2006-04-01)

Chronic Hepatitis C-Related Cirrhosis Hospitalization Cost Analysis in Bulgaria
by: Maria Dimitrova, et al.
Published: (2017-08-01)

Patients with alcohol-related liver disease hospitalized during the COVID-19 pandemic experienced worse outcomes
by: Lindsay A Sobotka, et al.
Published: (2023-05-01)

IL-1α correlates with severity of hepatitis C virus-related liver diseases
by: Tawfik AK, et al.
Published: (2018-07-01)

Hepatic decompensation associated with an interferon-free antiviral therapy in patients with HCV-cirrhosis
by: S N Batskikh, et al.
Published: (2018-11-01)

Short-term budget affordability of hepatitis C treatments for state Medicaid programs
by: Jacquelyn W. Chou, et al.
Published: (2019-02-01)

Triglyceride-Glucose Index is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients with HBV-Related Liver Cirrhosis
by: Yang SH, et al.
Published: (2024-04-01)